Jeffrey Bacha

Biography

Jeffrey Bacha, BSc, MBA has been our Chief Operating Officer since November 3, 2017, our President since January 25, 2013 and a director since February 11, 2013. He served as our chief executive officer from January 25, 2013 to November 3, 2017. Mr. Bacha is one of our founders and has been President and director of DelMar (BC) since inception. Mr. Bacha is a seasoned executive leader with nearly twenty years of life sciences experience in the areas of operations, strategy and finance. His background includes successful public and private company building from both a start-up and turn around perspective; establishing and leading thriving management and technical teams; and raising capital in both the public and private markets. From July 2006 to August 2009, Mr. Bacha was Executive Vice President Corporate Affairs and Chief Operating Officer at Clera, Inc. From March 2005 to July 2006 Mr. Bacha was Consultant and held various positions at Clera Inc., Urigen Holdings Inc. and XBiotech, Inc. From 1998 to 2002 MR. Bacha was Vice President of Corporate Development at Inflazyme Pharmaceuticals Ltd. From 2002 through 2005, Mr. Bacha served as founder, President & CEO of Inimex Pharmaceuticals, a venture-capital funded drug discovery and development company and is a former Senior Manager and Director of KPMG Health Ventures. Mr. Bacha holds an MBA from the Goizueta Business School at Emory University and a degree in BioPhysics from the University of California, San Diego. Mr. Bacha's experience as one of our founders and his scientific knowledge and experience qualify him to serve on our Board of Directors.

Research Interest

Biochemistry